REG - PureTech Health PLC - PDMR Notification RSU Vesting

Puretech HealthAnnouncement

Today 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nRSM4880Wa&default-theme=true

RNS Number : 4880W  PureTech Health PLC  13 March 2026

13 March 2026

PureTech Health plc

 

PDMR Notifications

 

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a
hub-and-spoke biotherapeutics company dedicated to giving life to science and
transforming innovation into value, announces that the award of restricted
share units ("RSUs") granted by PureTech on 22 May 2023 to a certain person
discharging managerial responsibilities ("PDMR") pursuant to its Performance
Share Plan ("PSP") vested on 11 March 2026 following satisfaction of certain
performance conditions measured over the three year period to 31 December
2025.

The PDMR received vested ordinary shares (after deduction of shares for
payroll taxes) on 12 March 2026. The market price per ordinary share in the
Company used to calculate the amount payable to the PDMR and the amount of
shares to be issued to the PDMR was 123.67 pence, being the average closing
price of the Company's shares over the three-trading day period immediately
preceding the vesting date, and the exchange rate used to calculate the cash
payment and amount of share settlement was £1: $1.34.

The Company's total issued ordinary share capital is 257,927,489 shares after
the share issuance to the PDMR, 14,859,738 shares of which are held in
treasury by the Company.

PDMR Notification

 

The information contained in the below notification is disclosed in accordance
with Article 19 of the EU Market Abuse Regulation.

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Eric Elenko
 2   Reason for the notification
 a)  Position/status                                              President
 b)  Initial notification/Amendment                               Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         PureTech Health plc
 b)  LEI                                                          213800LVPDNO2Z9T9I39
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary Shares of PureTech Health plc

                                                                  ISIN GB00BY2Z0H74
 b)  Nature of the transaction                                    Issuance of ordinary shares in net settlement of certain vested RSUs under the
                                                                  PureTech Health Performance Share Plan, after retentions in respect of payroll
                                                                  taxes.
 c)  Price(s) and volume(s)                                       Recipient    Price     Amount
                                                                  Eric Elenko  0.01 GBP  112,509 ordinary shares
 d)  Aggregated information                                       Price     Aggregate Volume

- Aggregated volume                                         0.01 GBP   112,509 ordinary shares

- Price
 e)  Date of the transaction                                      12 March 2026
 f)  Place of the transaction                                     London Stock Exchange (XLON)

b)

Nature of the transaction

Issuance of ordinary shares in net settlement of certain vested RSUs under the
PureTech Health Performance Share Plan, after retentions in respect of payroll
taxes.

c)

Price(s) and volume(s)

 Recipient    Price     Amount
 Eric Elenko  0.01 GBP  112,509 ordinary shares

d)

Aggregated information

 -  Aggregated volume

 -  Price

 Price     Aggregate Volume
 0.01 GBP   112,509 ordinary shares

e)

Date of the transaction

12 March 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

About PureTech Health

PureTech Health is a hub-and-spoke biotherapeutics company dedicated to
giving life to science and transforming innovation into value. We do this
through a proven, capital-efficient R&D model focused on opportunities
with validated pharmacology and untapped potential to address significant
patient needs. This strategy has produced dozens of therapeutic candidates,
including three that have received U.S. FDA approval. By identifying,
shaping, and de-risking these high-conviction assets, and scaling them through
dedicated structures backed by external capital, we accelerate their path to
patients while creating sustainable value for shareholders.

 

For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com) or connect with us on X (formerly Twitter)
@puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGPURAWUPQGRP



            Copyright 2019 Regulatory News Service, all rights reserved